In Chronic Myeloid Leukemia Patients on 2nd-Line Tyrosine Kinase Inhibitor Therapy, Deep Sequencing at the Time of Warning May Allow Sensitive Detection of Emerging BCR-ABL1 Mutants

Konference: 2014 56th ASH Annual Meeting - účast ČR

Kategorie: Maligní lymfomy a leukémie

Téma: 632. Chronic Myeloid Leukemia: Therapy: TKI cessation, monitoring and resistance

Číslo abstraktu: 815

Autoři: Simona Soverini; Caterina De Benedittis; Luca Zazzeroni; Mgr. Kateřina Machová (Poláková), Ph.D.; MD Fausto Castagnetti; Gabriele Gugliotta; Maria Teresa Bochicchio; Ilaria Iacobucci, PhD; MD Marzia Salvucci; MD Monica Crugnola; MD Gianni Binotto; Massimiliano Bonifacio; MD Giovanna Leonardi; MD Alessandra Iurlo; MD Giorgina Specchia; Prof. Domenico Russo; MD Fabrizio Pane; MD Giuseppe Saglio, PhD.; Prof. MD Gianantonio Rosti; MD Michele Cavo; MD Michele Baccarani; Prof.MD Giovanni Martinelli

Datum přednesení příspěvku: 9. 12. 2014